Back

Interleukin-6 inclusion adds value to the SMART risk score for prediction of cardiovascular death in patients with established ASCVD

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention: biomarkers to optimise outcomes Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Florian Kahles

RWTH University Hospital Aachen, Aachen (Germany)

5 More presentations in this session

Presentation thumbnail
Association of clinical, lifestyle, and genetic risk factors with outcomes after coronary artery bypass grafting
Mr J. Lambermont (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Optimizing long-term cardiovascular risk stratification: incorporating biomarkers into the atherosclerotic cardiovascular disease very high-risk definition
Doctor J. Cheng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Residual inflammation, cholesterol risks and rates of major cardiovascular events in routinely cared patients with atherosclerotic cardiovascular disease
Professor D. Capodanno (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Impact of baseline C-reactive protein on the efficacy and safety of rivaroxaban monotherapy in atrial fibrillation and stable coronary artery disease: a post-hoc AFIRE analysis
Doctor S. Kasukabe (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Recover with INOCA: A randomized, prospective study of a cardiac rehabilitation program in patients with ischemia with nonobstructive coronary artery disease (INOCA)
Miss M. Calvo Lopez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention: biomarkers to optimise outcomes
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Residual inflammatory risk: what is it and what can we do about it?
thumbnail
Congress Presentation
Coronary inflammation stratifies risk in patients undergoing coronary CT angiography: the Oxford Risk Factors and Non-Invasive Imaging (ORFAN) study
thumbnail
Congress Presentation
Residual inflammation, cholesterol risks and rates of major cardiovascular events in routinely cared patients with atherosclerotic cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources